Form DEF 14A - Other definitive proxy statements:
SEC Accession No. 0001193125-25-243037
Filing Date
2025-10-20
Accepted
2025-10-20 07:39:59
Documents
6
Period of Report
2025-11-21

Document Format Files

Seq Description Document Type Size
1 DEF 14A d847583ddef14a.htm DEF 14A 402570
2 GRAPHIC g847583g00n02.jpg GRAPHIC 40922
3 GRAPHIC g847583g00n03.jpg GRAPHIC 47545
4 GRAPHIC g847583g00n05.jpg GRAPHIC 40918
5 GRAPHIC g847583g01a01.jpg GRAPHIC 208316
6 GRAPHIC g847583g01a02.jpg GRAPHIC 196030
  Complete submission text file 0001193125-25-243037.txt   1116425
Mailing Address 828 WINTER STREET WALTHAM MA 02451
Business Address 828 WINTER STREET WALTHAM MA 02451 617-833-1027
Xilio Therapeutics, Inc. (Filer) CIK: 0001840233 (see all company filings)

EIN.: 851623397 | State of Incorp.: DE | Fiscal Year End: 1231
Type: DEF 14A | Act: 34 | File No.: 001-40925 | Film No.: 251402330
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)